Table 2.

Current JAK inhibitor clinical trials for patients with an MPN

Current JAK inhibitor clinical trials for patients with an MPN

IMID indicates immunomodulatory drugs; N/A, not applicable.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal